IDEAYA Biosciences Employee Directory
Biotechnology ResearchCalifornia, United States201-500 Employees
IDEAYA Biosciences is a biotechnology company focused on oncology and precision medicine. It pursues discovery and development of targeted therapeutics for patient populations defined by molecular diagnostics, with a primary emphasis on synthetic lethality as a class of precision medicine targets. Headquartered in South San Francisco, California, IDEAYA is a mid-sized firm focused on advancing this agenda. In June 2026, the company announced the launch of IDE892, a potential best-in-class MTA-Cooperative PRMT5 inhibitor, initiating a Phase 1/2 study in MTAP-deleted pancreatic and lung cancers.